Average Co-Inventor Count = 5.72
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novartis Ag (16 from 3,923 patents)
2. Dana-farber-cancer Institute Inc. (3 from 1,209 patents)
16 patents:
1. 11382905 - Immunomodulation by IAP inhibitors
2. 10786491 - Immunomodulation by IAP inhibitors
3. 9750729 - Immunomodulation by IAP inhibitors
4. 8993523 - Dimeric IAP inhibitors
5. 8906936 - Pharmaceutical combination comprising co-administration of taxane and N-(1-cyclohexyl-2-{2-[4-(4-fluoro-benzoyl)-thiazol-2-yl]-pyrrolidin-1-yl}-2-oxo-ethyl)-2-methylamino-propionamide or pharmaceutically acceptable salt(s) thereof
6. 8552003 - (S)-N-((S)-1-cyclohexyl-2-{(S)-2-[4-4-(4-fluorobenzoyl)-thiazol-2-yl]pyrrolidin-1-yl}-2-oxoethyl)-2-methylamino-propionamide, or pharmaceutically acceptable salts thereof and their uses
7. 8546336 - SMAC peptidometics useful as IAP inhibitors
8. 8445440 - Dimeric IAP inhibitors
9. 8338440 - Inhibitors of IAP
10. 8207183 - Inhibitors of IAP
11. 8058272 - Organic compounds
12. 8048886 - Substituted pyrazine-3-one-derivatives as IAP inhibitors
13. 8044209 - Pyrrolydine derivatives as IAP inhibitors
14. 7989441 - Organic compounds
15. 7932255 - 2-aminocarbonyl substituted piperazine or diaza-cyclic compounds as apoptosis protein inhibitors (lap) modulators